Početna › Shizofrenija › Arkansas
Kliničke studije za Shizofrenija u državi Arkansas
21 studija za Shizofrenija traži sudionike na lokacijama u državi Arkansas.
Gradovi u državi Arkansas
Službeni tekst studije (engleski)
Safety and Tolerability of Open-Labeled Iloperidone in Adolescents
- Vanda Investigational Site, Little Rock
U tijeku regrutacijaFaza 4
Od 12 do 17 godina · Oba spola · Ažurirano 1. lis 2026. · NCT05648591Relapse Prevention Trial Evaluating KarXT Treatment in Schizophrenia
- Pillar Clinical Research - Bentonville, Bentonville
- Pillar Clinical Research- Little Rock, Little Rock
- Local Institution - 0021, Little Rock
- i još 1
U tijeku regrutacijaFaza 3
Od 18 do 65 godina · Oba spola · Ažurirano 28. ruj 2026. · NCT07686263Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum Disorder
- Pillar Clinical Research, LLC, Little Rock
U tijeku regrutacijaFaza 3
Od 5 do 17 godina · Oba spola · Ažurirano 25. ruj 2026. · NCT06229210NBI-1117568-SCZ3030: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia
- Neurocrine Clinical Site, Little Rock
U tijeku regrutacijaFaza 3
Od 18 do 65 godina · Oba spola · Ažurirano 25. ruj 2026. · NCT07105098NBI-1117568-SCZ3032: Long-Term Evaluation of NBI-1117568 in Adults With Schizophrenia
- Neurocrine Clinical Site, Bryant
- Neurocrine Clinical Site, Little Rock
U tijeku regrutacijaFaza 3
Od 18 do 65 godina · Oba spola · Ažurirano 25. ruj 2026. · NCT07114874Study to Evaluate the Safety and Efficacy of Ublituximab in Participants With Schizophrenia
- TG Therapeutics Investigational Trial Site, Little Rock
U tijeku regrutacijaFaza 2
Od 18 do 60 godina · Oba spola · Ažurirano 23. ruj 2026. · NCT07680946A Study of Brenipatide in Adult Participants With Schizophrenia
- Pillar Clinical Research- Little Rock, Little Rock
U tijeku regrutacijaFaza 2
Od 18 do 55 godina · Oba spola · Ažurirano 22. ruj 2026. · NCT07410507A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor
- Neurocrine Clinical Site, Bryant
U tijeku regrutacijaFaza 4
Od 18 godina i više · Oba spola · Ažurirano 18. ruj 2026. · NCT07105111A Study of LTX-001 In Adult Participants With Acute Exacerbation of Schizophrenia
- Pillar Clinical Research, LLC, Little Rock
U tijeku regrutacijaFaza 1
Od 18 do 55 godina · Oba spola · Ažurirano 17. ruj 2026. · NCT07734493A Study to Assess Adverse Events, Change in Disease Activity, and How Oral Emraclidine Moves Through the Body in Adult Participants With Schizophrenia
- Woodland International Research Group /ID# 275747, Little Rock
U tijeku regrutacijaFaza 2
Od 18 do 65 godina · Oba spola · Ažurirano 15. ruj 2026. · NCT0714591852-week Open Label Safety-Tolerability Study
- Pillar Clinical Research, Bentonville
- Pillar Clinical Research, Little Rock
- Woodland International Research Group, Little Rock
U tijeku regrutacijaFaza 3
Od 18 do 65 godina · Oba spola · Ažurirano 9. ruj 2026. · NCT07369154A Long-Term Open-Label Study of ML-007C-MA in Adults With Schizophrenia
- Clinical Site, Little Rock
- Clinical Site, Little Rock
- Clinical Site, Rogers
U tijeku regrutacijaFaza 2
Od 18 do 65 godina · Oba spola · Ažurirano 1. ruj 2026. · NCT07459647Effectiveness and Adverse-effect Switch Evaluation of Xanomeline and Trospium Chloride (KarXT)
- SanRo Clinical Research Group, Bryant
U tijeku regrutacijaOpažajna studija
Od 18 godina i više · Oba spola · Ažurirano 19. kol 2026. · NCT07379827Study to Evaluate Weight Gain as Assessed by Change in BMI Z-score in Pediatric Subjects With Schizophrenia or Bipolar I Disorder
- Alkermes Investigator Site, Little Rock
U tijeku regrutacijaFaza 3
Od 10 do 17 godina · Oba spola · Ažurirano 14. kol 2026. · NCT05303064Study to Assess the Safety, Tolerability, and Treatment Response of GXV813 in Hospitalized Adults With Schizophrenia
- Pillar Clinical Research LLC, Bentonville
U tijeku regrutacijaFaza 2
Od 18 do 65 godina · Oba spola · Ažurirano 29. srp 2026. · NCT07467993Study to Evaluate LB-102 for the Treatment of Adult Patients With Acute Schizophrenia
- Pillar Clinical Research, Bentonville
- Pillar Clinical Research, Little Rock
- Woodland International Research Group, Little Rock
U tijeku regrutacijaFaza 3
Od 18 do 65 godina · Oba spola · Ažurirano 27. srp 2026. · NCT07363577A Study to Evaluate KYN-5356 in Adults With Cognitive Impairment Associated With Schizophrenia
- Woodland International Research Group, Little Rock
U tijeku regrutacijaFaza 2
Od 18 do 55 godina · Oba spola · Ažurirano 23. lip 2026. · NCT07191483A Study to Evaluate the Effect of KarXT on Urological Safety
- Pillar Clinical Research- Little Rock, Little Rock
U tijeku regrutacijaFaza 4
Od 18 do 65 godina · Oba spola · Ažurirano 3. lip 2026. · NCT07221877NBI-1117568-SCZ3029: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia
- Neurocrine Clinical Site, Bryant
- Neurocrine Clinical Site, Little Rock
U tijeku regrutacijaFaza 3
Od 18 do 65 godina · Oba spola · Ažurirano 6. ožu 2026. · NCT06963034Randomized Withdrawal Study in Patients With Schizophrenia
- Vanda Investigational Site, Rogers
U tijeku regrutacijaFaza 3
Od 18 do 65 godina · Oba spola · Ažurirano 12. sij 2026. · NCT06961968Safety and Efficacy of Brilaroxazine (RP5063) in Schizophrenia
- Reviva site, Bentonville
- Reviva site, Little Rock
- Reviva site, Rogers
U tijeku regrutacijaFaza 3Zdravi dobrovoljci dobrodošli
Od 18 do 65 godina · Oba spola · Ažurirano 19. pro 2024. · NCT05184335Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.